An ongoing dialogue on HIV/AIDS, infectious diseases,
November 8th, 2015
New HIV Treatment “ECF-TAF” is Really All About the “TAF” Part
HIV providers and patients recently got this news from the FDA: The U.S. Food and Drug Administration today approved Genvoya (a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients 12 years of age and older. (Disclosure: I have been […]